Psychopharmacologic Therapies for Irritable Bowel Syndrome (Abstract)

Gastroenterol Clin North Am
Epub 01 July 2021
https://pubmed.ncbi.nlm.nih.gov/34304793/

Katie gives an update on taking LDN for Fibromyalgia, Interstitial Cystitis, GERD, IBS (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Katie from the US gives as an update on taking Low Dose Naltrexone (LDN) for Fibromyalgia, Interstitial Cystitis, GERD, IBS.

Low-Dose Naltrexone for Treating MS Symptoms

Verywell Health
05 January 2020
https://www.verywellhealth.com/naltrexone-for-ms-2440888

Low-Dose Naltrexone for Pruritus in Systemic Sclerosis

Int J Rheumatol
12 September 2011
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171757/

Low-Dose Naltrexone (LDN) Treatment for Crohn's Disease (CD): A Tertiary Care Center Experience

Am J Gastroenterol
October 2011
https://journals.lww.com/ajg/Fulltext/2011/10002/Low_Dose_Naltrexone__LDN__Treatment_for_Crohn_s.1223.aspx

Safety and tolerability of Low-Dose Naltrexone therapy in children with moderate to severe Crohn's disease: a pilot study

J Clin Gastroenterol
01 April 2014
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586944/

Background
There is an unmet need for safe and effective medicines to treat children with Crohn’s disease. Recently, investigations have shown an association between endogenous opioid peptides and inflammatory cells.

P388 Immunological changes in IBD patients responding to low-dose naltrexone treatment

J Crohn's and Colitis
01 February 2012
https://academic.oup.com/ecco-jcc/article/6/Supplement_1/S164/369091

P418 Low dose naltrexone in therapy resistant IBD, a case series

J Crohn's and Colitis
February 2014
https://www.gastrojournal.org/article/S0016-5085(14)61660-7/pdf